1. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential

   • Anna Serafini
   • Elizabeth Gerard
   • Philippe Gelisse

   Current Opinion 11 February 2019 Pages: 195 - 208

2. Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases

   • Andre F. Batista
   • Victor Bodart-Santos
   • Sergio T. Ferreira

   Leading Article 03 December 2018 Pages: 209 - 223

   

3. Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis

   • Shih-Yu Chen
   • Gopi Ravindran
   • Dan Siskind

   Systematic Review 13 February 2019 Pages: 225 - 238

   

4. Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis

   • Abdelrahman Elshafay
   • Truong Hong Hieu
   • Nguyen Tien Huy

   Systematic Review 22 February 2019 Pages: 239 - 250

   

5. A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment

   • Brati Das
   • Riqiang Yan

   Review Article 04 March 2019 Pages: 251 - 263

   

6. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development

   • Ariela Frieder
   • Madeleine Fersh
   • Kristina M. Deligiannidis

   Review Article 21 February 2019 Pages: 265 - 282

7. A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy

   • Zeinab Gharaylou
   • Abbas Tafakhori
   • Mahmoudreza Hadjighassem

   Original Research Article 19 February 2019 Pages: 283 - 291

   

8. Comment on: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis”

   • Georgios Tsivgoulis
   • Lina Palaiodimou
   • Nikolaos Grigoriadis

   Letter to the Editor 26 February 2019 Pages: 293 - 295

9. Authors’ Reply to Tsivgoulis et al.: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis”

   • Dimitrios Papadopoulos
   • Dimos-Dimitrios D. Mitsikostas

   Letter to the Editor 26 February 2019 Pages: 297 - 298

10. Correction to: Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research

    • Yvonne Höller
    • Christoph Helmstaedter
    • Klaus Lehnertz

    Correction Open access 26 February 2019 Pages: 299 - 299